---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-024881"
form_type: "8-K"
ticker: "BFRI"
cik: "0001858685"
company_name: "Biofrontera Inc."
filed_at: "2024-06-24T23:59:59+00:00"
generated_at: "2026-06-01T02:35:37.510636+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Biofrontera launches FDA-approved RhodoLED XL lamp for PDT of actinic keratoses

## Summary
- RhodoLED XL is FDA-approved for use with Ameluz (aminolevulinic acid) for mild-to-moderate actinic keratoses on face and scalp.
- Commercial distribution launched June 10, 2024; first three machines shipped within one week.
- Larger illumination area: five panels vs one on prior lamp; includes positioning sensors for optimal energy delivery.
- First customer Cleaver Dermatology (MO and GA) installed the XL lamp; response from dermatology organizations is positive.

## SEC filing metadata
- accession: 0001493152-24-024881
- form_type: 8-K
- ticker: BFRI
- cik: 0001858685
- company_name: Biofrontera Inc.
- filed_at: 2024-06-24T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858685/000149315224024881/0001493152-24-024881-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858685/000149315224024881/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-024881
- JSON: https://secwatch.observer/filing/0001493152-24-024881.json
- Plain text: https://secwatch.observer/filing/0001493152-24-024881.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.